Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury

Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31 Ostermann M, Chang RW (2007) Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 35:1837–1843, quiz 1852 Kelly KJ, Molitoris BA (2000) Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 20:4–19 Kalantarinia K (2009) Novel imaging techniques in acute kidney injury. Curr Drug Targets 10:1184–1189 Andreucci M, Faga T, Pisani A et al (2014) Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int 2014:362725 Susantitaphong P, Eiam-Ong S (2014) Nonpharmacological strategies to prevent contrast-induced acute kidney injury. Biomed Res Int 2014:463608 Kogan PJK, Johnson KA, Feingold S et al (2011) Validation of dynamic contrast-enhanced ultrasound in rodent kidneys as an absolute quantitative method for measuring blood perfusion. Ultrasound Med Biol 37:900–9008 Feingold S, Gessner R, Guracar IM, Dayton PA (2010) Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol 45:669–674 McArthur C, Baxter GM (2012) Current and potential renal applications of contrast-enhanced ultrasound. Clin Radiol 67:909–922 Lassau N, Chapotot L, Benatsou B et al (2012) Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study. Invest Radiol 47:711–716 Lassau N, Chami L, Benatsou B et al (2007) Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 17(Suppl 6):F89–98 Mahoney M, Sorace A, Warram J et al (2014) Volumetric contrast-enhanced ultrasound imaging of renal perfusion. J Ultrasound Med 33:1427–1437 Saini R, Hoyt K (2014) Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis. Imaging Med 6:41–52 Hoyt K, Mahoney M, Sorace A (2014) Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer. Proc IEEE Ultrason Sympos 1160–1163 Saini R, Sorace AG, Warram JM et al (2013) An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound Med Biol 39:172–180 Knowles JA, Heath CH, Saini R et al (2012) Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 138:662–668 Sorace AG, Saini R, Mahoney M, Hoyt K (2012) Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy. J Ultrasound Med 31:1543–1550 Warram JM, Sorace AG, Saini R et al (2011) A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 30:921–931 Lindner JR, Song J, Christiansen J et al (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104:2107–2112 Boesen EI, Crislip GR, Sullivan JC (2012) Use of ultrasound to assess renal reperfusion and P-selectin expression following unilateral renal ischemia. Am J Physiol Renal Physiol 303:F1333–1340 Andonian S, Coulthard T, Smith AD et al (2009) Real-time quantitation of renal ischemia using targeted microbubbles: in-vivo measurement of P-selectin expression. J Endourol 23:373–378 Klibanov AL (2009) Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging. Med Biol Eng Comput 47:875–882 Warram JM, Sorace AG, Mahoney M et al (2014) Biodistribution of P-selectin targeted microbubbles. J Drug Target 22:387–394 Roberts J, Chen B, Curtis LM et al (2007) Detection of early changes in renal function using 99mTc-MAG3 imaging in a murine model of ischemia-reperfusion injury. Am J Physiol Renal Physiol 293:F1408–1412 Frinking PJ, Bouakaz A, Kirkhorn J et al (2000) Ultrasound contrast imaging: current and new potential methods. Ultrasound Med Biol 26:965–975 Sorace A, Hoyt K (2014) Imaging the microvascular response to ultrasound-stimulated therapy in a preclinical animal model of breast cancer. Proc IEEE Ultrasonics Sympos 2145–2148 Yusuf GT, Sellars ME, Huang DY et al (2014) Cortical necrosis secondary to trauma in a child: contrast-enhanced ultrasound comparable to magnetic resonance imaging. Pediatr Radiol 44:484–487 Schneider AG, Goodwin MD, Schelleman A et al (2014) Contrast-enhanced ultrasonography to evaluate changes in renal cortical microcirculation induced by noradrenaline: a pilot study. Crit Care 18:653 Schneider AG, Schelleman A, Goodwin MD et al (2015) Contrast-enhanced ultrasound evaluation of the renal microcirculation response to terlipressin in hepato-renal syndrome: a preliminary report. Ren Fail 37:175–179 Fröhlich E, Muller R, Cui XW et al (2015) Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion. J Ultrasound Med 34:179–196 Göcze I, Wohlgemuth WA, Schlitt HJ, Jung EM (2014) Contrast-enhanced ultrasonography for bedside imaging in subclinical acute kidney injury. Intensive Care Med 40:431 Ferrante EA, Pickard JE, Rychak J et al (2009) Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 140:100–107 Bettinger T, Bussat P, Tardy I et al (2012) Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species. Invest Radiol 47:516–523 Willmann JK, Lutz AM, Paulmurugan R et al (2008) Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 248:936–944 Hoyt K, Sorace A, Saini R (2012) Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound. Invest Radiol 47:167–174 Hoyt K, Sorace A, Saini R (2012) Volumetric contrast-enhanced ultrasound imaging to assess early response to apoptosis-inducing anti-death receptor 5 antibody therapy in a breast cancer animal model. J Ultrasound Med 31:1759–1766 Pollard RE, Dayton PA, Watson KD et al (2009) Motion corrected cadence CPS ultrasound for quantifying response to vasoactive drugs in a rat kidney model. Urology 74:675–681 Waikar SS, Betensky RA, Bonventre JV (2009) Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 24:3263–3265 Waikar SS, Betensky RA, Emerson SC, Bonventre JV (2012) Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 23:13–21